Rapidity of onset of response to adalimumab in luminal Crohn's disease. Data from RAPIDA trial

被引：0
|
作者：
Marin-Jimenez, I. [1 ]
Casellas, F. [2 ]
Esteve, M. [3 ]
Castro-Laria, L. [4 ]
Garcia-Lopez, S. [5 ]
Ceballos, D. [6 ]
Echarri, A. [7 ]
Martin-Arranz, M. D. [8 ]
Busquets, D. [9 ]
Llao, J. [10 ]
Navarro-Llavat, M. [11 ]
Huguet, J. M. [12 ]
Arguelles-Arias, F. [4 ]
Vicente, R. [5 ]
Rodriguez-San Pedro, L. [13 ]
Diaz, G. [14 ]
Casado, R. [14 ]
Barreiro-de Acosta, M. [15 ]
机构：
[1] Hosp Univ Gregorio Maranon, IiSGM, Madrid, Spain
[2] Hosp Univ Vall dHebron, Gastroenterol, Barcelona, Spain
[3] Hosp Univ Mutua Terrassa, Barcelona, Spain
[4] Hospit Univ Virgen Macarena Rocio, Seville, Spain
[5] Hosp Univ Miguel Servet, Zaragoza, Spain
[6] Dr Negrin Univ Hosp, Las Palmas Gran Canaria, Spain
[7] Complejo Hosp Univ Ferrol, Ferrol, Spain
[8] Hosp Univ La Paz, Madrid, Spain
[9] Hosp Univ Dr Josep Trueta, Girona, Spain
[10] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain
[11] Hosp St Joan Despi Moises Broggi, Barcelona, Spain
[12] Hosp Gen Univ Valencia, Valencia, Spain
[13] AbbVie Spain, Madrid, Spain
[14] AbbVie Farmaceut SLU, Inmunol, Madrid, Spain
[15] Hosp Clin Univ Santiago, Santiago De Compostela, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P618
引用
收藏
页码：S395 / S396
页数：2
相关论文
共 50 条
  • [1] RAPIDITY OF ONSET OF RESPONSE TO ADALIMUMAB (ADA) IN LUMINAL CROHN DISEASE (CD). DATA FROM RAPIDA TRIAL
    Marin-Jimenez, Ignacio
    Casellas, Francesc
    Esteve, Maria
    Castro-Laria, L.
    Garcia-Lopez, Santiago
    Ceballos, Daniel
    Echarri, Ana
    Martin-Arranz, M. D.
    Busquets, David
    Llao, Jordina
    Huguet, Jose Maria
    Arguelles-Arias, Federico
    Vicente, Raquel
    Rodriguez-SanPedro, Lucia
    Diaz, Gema
    Casado, Rocio
    Barreiro, Manuel
    GASTROENTEROLOGY, 2017, 152 (05) : S776 - S776
  • [2] Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study
    Marin-Jimenez, Ignacio
    Barreiro-de Acosta, Manuel
    Esteve, Maria
    Castro-Laria, Luisa
    Garcia-Lopez, Santiago
    Ceballos, Daniel
    Echarri, Ana
    Martin-Arranz, Maria Dolores
    Busquets, David
    Llao, Jordina
    Navarro-Llavat, Merce
    Huguet, Jose Maria
    Arguelles-Arias, Federico
    Vicente, Raquel
    Boudet, Jose Miguel
    Diaz, Gema
    Sanchez-Migallon, Ana M.
    Casellas, Francesc
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (03): : 165 - 176
  • [3] Early improvement in quality of life in patients with luminal Crohn's disease treated with adalimumab. Data from RAPIDA trial
    Casellas, F.
    Acosta, M. Barreiro-de
    Esteve, M.
    Castro-Laria, L.
    Vicente, R.
    Ceballos, D.
    Echarri, A.
    Martin-Arranz, M. D.
    Busquets, D.
    Llao, J.
    Navarro-Llavat, M.
    Huguet, J. M.
    Argelles-Arias, F.
    Boudet, J. M.
    Pedro, L. Rodriguez-San
    Diaz, G.
    Casado, R.
    Marin, I.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S291 - S292
  • [4] Metastatic Crohn's disease. Response to adalimumab dose intensification
    Lazaro Saez, Marta
    Hernandez Martinez, Alvaro
    Bendezu Garcia, Roger Alvaro
    Rodriguez Manrique, Marco Antonio
    Simon Lopez, Francisca
    Medina Estevez, Emilia
    Vega Saenz, Jose Luis
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (05): : 321 - 325
  • [5] Small intestinal luminal pH in Crohn's disease.
    Nugent, SG
    Rampton, DS
    Evans, DF
    Yazaki, E
    Kumar, D
    GUT, 2000, 46 : A9 - A9
  • [6] Adalimumab in Crohn's disease - data from real life
    San Roman, A. Lopez
    Van Domselaar, M.
    Garrido, E.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2008, 100 (11) : 671 - 675
  • [7] Infliximab is steroid-sparing in luminal Crohn's disease.
    Cohen, RD
    Papalia, P
    Hanauer, SB
    GASTROENTEROLOGY, 2001, 120 (05) : A620 - A620
  • [8] Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
    Rutgeerts, Paul
    Van Assche, Gert
    Sandborn, William J.
    Wolf, Douglas C.
    Geboes, Karel
    Colombel, Jean-Frederic
    Reinisch, Walter
    Kumar, Ashish
    Lazar, Andreas
    Camez, Anne
    Lomax, Kathleen G.
    Pollack, Paul F.
    D'Haens, Geert
    GASTROENTEROLOGY, 2012, 142 (05) : 1102 - +
  • [9] Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohn's Disease
    Bouguen, Guillaume
    Laharie, David
    Nancey, Stephane
    Hebuterne, Xavier
    Flourie, Bernard
    Filippi, Jerome
    Roblin, Xavier
    Trang, Caroline
    Bourreille, Arnaud
    Babouri, Abdenour
    Bretagne, Jean-Francois
    Siproudhis, Laurent
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (05) : 1047 - 1053
  • [10] Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
    Colombel, Jean-Frederic
    Sandborn, William J.
    Rutgeerts, Paul
    Enns, Robert
    Hanauer, Stephen B.
    Panaccione, Remo
    Schreiber, Stefan
    Byczkowski, Dan
    Li, Ju
    Kent, Jeffrey D.
    Pollack, Paul F.
    GASTROENTEROLOGY, 2007, 132 (01) : 52 - 65
12345